Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2007 1
2010 1
2011 1
2014 1
2017 1
2018 1
2020 1
2021 5
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Colon cancer.
Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Labianca R, et al. Among authors: milesi l. Crit Rev Oncol Hematol. 2010 May;74(2):106-33. doi: 10.1016/j.critrevonc.2010.01.010. Crit Rev Oncol Hematol. 2010. PMID: 20138539 Review.
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.
Palmerini E, Sanfilippo R, Grignani G, Buonadonna A, Romanini A, Badalamenti G, Ferraresi V, Vincenzi B, Comandone A, Pizzolorusso A, Brunello A, Gelsomino F, De Pas T, Ibrahim T, Gurrieri L, Grosso F, Zanelli F, Pantaleo MA, Milesi L, Ciuffreda L, Ferrari V, Marchesi E, Quattrini I, Righi A, Setola E, Carretta E, Casali PG, Picci P, Ferrari S. Palmerini E, et al. Among authors: milesi l. Front Oncol. 2022 Dec 8;12:1042479. doi: 10.3389/fonc.2022.1042479. eCollection 2022. Front Oncol. 2022. PMID: 36568164 Free PMC article.
Recurrent retroperitoneal solitary fibrous tumor: a case report.
Manica M, Roscigno M, Naspro R, Sodano M, Milesi L, Gianatti A, Da Pozzo LF. Manica M, et al. Among authors: milesi l. Tumori. 2021 Dec;107(6):NP11-NP14. doi: 10.1177/0300891620974763. Epub 2020 Nov 25. Tumori. 2021. PMID: 33238803
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
Tropea S, Del Fiore P, Maurichi A, Patuzzo R, Santinami M, Ribero S, Quaglino P, Caliendo V, Borgognoni L, Sestini S, Giudice G, Nacchiero E, Caracò C, Cordova A, Solari N, Piazzalunga D, Tauceri F, Carcoforo P, Lombardo M, Cavallari S, Mocellin S; Italian Melanoma Intergroup (IMI). Tropea S, et al. BMC Cancer. 2022 Jun 3;22(1):610. doi: 10.1186/s12885-022-09705-y. BMC Cancer. 2022. PMID: 35659273 Free PMC article.
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.
Palmerini E, Sanfilippo R, Grignani G, Buonadonna A, Romanini A, Badalamenti G, Ferraresi V, Vincenzi B, Comandone A, Pizzolorusso A, Brunello A, Gelsomino F, Pas T, Ibrahim T, Grosso F, Zanelli F, Pantaleo MA, Milesi L, Ciuffreda L, Ferrari V, Marchesi E, Quattrini I, Righi A, Setola E, Carretta E, Picci P, Ferrari S. Palmerini E, et al. Among authors: milesi l. Cancers (Basel). 2021 Mar 2;13(5):1053. doi: 10.3390/cancers13051053. Cancers (Basel). 2021. PMID: 33801399 Free PMC article.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Zambelli A, Chiudinelli L, Fotia V, Negrini G, Bosetti T, Callegaro A, Di Croce A, Caremoli ER, Moro C, Milesi L, Poletti P, Tasca C, Mandalà M, Merelli B, Mosconi S, Arnoldi E, Bettini A, Bonomi L, Messina C, Ghilardi L, Chirco A, Maracino M, Tondini C. Zambelli A, et al. Among authors: milesi l. Oncologist. 2021 Apr;26(4):341-347. doi: 10.1002/onco.13654. Epub 2021 Jan 7. Oncologist. 2021. PMID: 33355953 Free PMC article.
Dermanet--a tailor-made tool for teledermatology...
Kühnis L, Milesi L. Kühnis L, et al. Among authors: milesi l. Curr Probl Dermatol. 2003;32:154-7. doi: 10.1159/000067373. Curr Probl Dermatol. 2003. PMID: 12472005 No abstract available.
15 results